A company positioned to deliver revolutionary cancer vaccines, empowering the future through Precision Immunomics™ technology.

Infinitopes

Infinitopes is a pioneer in precision immunomics medicines. A Cancer Research UK (CRUK)-led biotech spinout from Oxford University, we are empowering the immune system to fight cancer metastases with unique, de novo antigen discovery technologies, innovative high efficiency vectors and intelligent clinical trial design. Our mission is to significantly enhance patient survival.

COM:INFINITOPES

Infinitopes

locale

market

industry

website

linkedin

investor of

Metrics